4//SEC Filing
ANADYS PHARMACEUTICALS INC 4
Accession 0001104659-05-027202
CIK 0001128495operating
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 9:28 PM ET
Size
51.1 KB
Accession
0001104659-05-027202
Insider Transaction Report
Form 4
HBM BIOVENTURES AG
10% Owner
Transactions
- Sale
Common Stock
2005-06-03$7.90/sh−6,902$54,526→ 2,580,925 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$7.92/sh−2,300$18,216→ 2,573,826 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$8.00/sh−9,400$75,200→ 2,525,077 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$8.09/sh−1,100$8,899→ 2,503,477 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$7.95/sh−7,050$56,048→ 2,558,577 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$8.01/sh−3,800$30,438→ 2,521,277 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$7.88/sh−1,900$14,972→ 2,589,827 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$7.97/sh−15,150$120,746→ 2,542,927 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$8.07/sh−4,359$35,177→ 2,504,577 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$8.32/sh−48$399→ 2,496,627 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$7.89/sh−2,000$15,780→ 2,587,827 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$8.10/sh−2,600$21,060→ 2,500,877 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$7.86/sh−600$4,716→ 2,596,027 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$7.93/sh−4,500$35,685→ 2,569,326 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$7.98/sh−4,450$35,511→ 2,538,477 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$7.99/sh−4,000$31,960→ 2,534,477 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$7.87/sh−4,300$33,841→ 2,591,727 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$7.94/sh−3,699$29,370→ 2,565,627 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$8.03/sh−4,241$34,055→ 2,511,686 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$7.91/sh−4,799$37,960→ 2,576,126 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$7.96/sh−500$3,980→ 2,558,077 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$8.02/sh−5,350$42,907→ 2,515,927 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$8.30/sh−352$2,922→ 2,496,675 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$8.04/sh−1,950$15,678→ 2,509,736 total(indirect: By HBM BioVentures (Cayman) Ltd.) - Sale
Common Stock
2005-06-03$8.05/sh−800$6,440→ 2,508,936 total(indirect: By HBM BioVentures (Cayman) Ltd.)
Footnotes (2)
- [F1]HBM BioVentures AG (the "Reporting Entity") is the sole shareholder of HBM BioVentures (Cayman) Ltd. ("HBM"), the entity that owns the reported securities.
- [F2]N/A
Documents
Issuer
ANADYS PHARMACEUTICALS INC
CIK 0001128495
Entity typeoperating
Related Parties
1- filerCIK 0001128495
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 9:28 PM ET
- Size
- 51.1 KB